Cited by 2Mobile Health and mHealth ApplicationsCardiac Health and Mental HealthAcute Myocardial Infarction Research

Abstract 26: The Corrie Myocardial infarction, COmbined-device, Recovery Enhancement (MiCORE) Study: 30-Day Readmission Rates and Cost-Effectiveness of a Novel Digital Health Intervention for Acute Myocardial Infarction Patients

Marvel, Francoise A, Spaulding, Erin M, Lee, Matthias, Yang, William, Martin, Seth S·2019·Circulation: Cardiovascular Quality and Outcomes

Abstract

Purpose: Determine if acute myocardial infarction (AMI) patients using a novel digital health intervention, the Corrie Health Digital Platform (Corrie), have reduced 30-day hospital readmissions and related healthcare costs compared to a historical comparison group. Methods: Corrie is deployed to patients admitted to Johns Hopkins Hospital, Johns Hopkins Bayview Medical Center, Massachusetts General Hospital, and Reading Hospital for an AMI (STEMI or type 1 NSTEMI), as early as possible during their hospitalization in the inpatient cardiac units. AMI patients are enrolled if they are: over 18 years old; English-speaking; without auditory, visual, cognitive, or physical impairment; and own a smartphone. Corrie is deployed to patients using a standard operating procedure and consists of the following: (1) a smartphone medication, education, vitals, and follow-up appointments self-management app, (2) smartwatch for reminders and heart rate and physical activity tracking, and (3) a Bluetooth-enabled blood pressure cuff. Patients are either enrolled with their personal iPhone or a loaner iPhone, if they own any other type of smartphone, and a loaner smartwatch for usage during the 30 day study period. The historical comparison group consists of AMI patients, admitted at the same hospitals from October 1 st 2015-2016, who did not receive Corrie. All-cause readmission rates will be evaluated at 30 days after discharge in both groups and Cox proportional hazard models will be used to test differences in time to all-cause first readmission within 30 days between groups, controlling for covariates. To assess cost-effectiveness of Corrie, a Markov Model of cost-effectiveness will be built, based on 30-day readmission rates, to assess the Incremental Cost-Effectiveness Ratio of adopting Corrie. Results/Conclusions: The MiCORE study is being completed and results will be available for AHA QCOR by April 2019.

Integrity signals

Registry

Crossref · 10.1161/hcq.12.suppl_1.26

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In patients with type I myocardial infarction, the MICORE study showed that a mobile app platform (including a smartwatch) improved secondary prevention management by reducing hospital readmissions and cost.

    “In patients with type I myocardial infarction, the MICORE study76 showed that a mobile app platform (including a smartwatch) improved secondary prevention management by reducing hospital readmissions and cost”
  • In the MiCORE study, preliminary results from 164 patients showed a 43% lower likelihood of hospital readmission at 30 days among participants receiving a guideline-driven, self-management programme than among participants in a propensity-matched, historical comparison group.

    “Preliminary results from 164 patients showed a 43% lower likelihood of hospital readmission at 30 days among participants receiving a guideline-driven, self-management programme than among participants in a propensity-matched, historical comparison group (n = 695)76.”

Cited by

Sorted by citations

Authors
Marvel, F. A., Spaulding, E. M., Lee, M., Yang, W., & Martin, S. S.
Affiliations
  • École Polytechnique (FR)
  • Johns Hopkins University (US)
  • Ciccarone Preventive Cardiology Cntr, Baltimore, MD
Venue
Circulation: Cardiovascular Quality and Outcomes
Published
2019-04
Volume
12
Issue
Suppl_1
ISSN
  • 1941-7705 (ISSN-L)
  • 1941-7713
OpenAlex
W2926272665
Cited by
2
References
0
Citations by year
2021: 2
Type
conference abstract
Language
en
Open access
closed
Locations
Circulation Cardiovascular Quality and Outcomes (publishedVersion)
Topics
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
Keywords
acute myocardial infarction, digital health interventions, mobile application, smartwatches, 30-day readmission, cost-effectiveness, medication self-management, patient education, Markov model

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review